Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page
or, investors have finally determined that Allergan's numbers are complete shit. Full year guidance of GAAP losses of $12 a share, but "non-GAAP" earnings of $16 a share ... Only at Valeant would you see manipulation like that! Even beating revenue numbers didn't get any movement.
The 6 months ending June of 2016 Allergan had an operating loss of $659 million. for the 6 months ending June for 2017, that operating loss was $1.8 billion.
That's 174% more in operating losses. I'm pretty sure that we have operated at a loss every quarter for two years. It proves that you can be horrible at your job and be in a position of power. Atta boy Brent...you are killing it!